Finland's medicines regulator, a central agency under the Ministry of Social Affairs and Health. Medicines with a new active substance for cancer must go through the European Medicines Agency's centralised procedure, in which Fimea's pages describe Finland acting as a rapporteur.
The Finnish Medicines Agency Fimea describes itself as the national competent authority for regulating pharmaceuticals, a central administrative agency operating under the Ministry of Social Affairs and Health that regulates medicinal products, medical devices, blood and tissue products and biobanks, and develops the pharmaceuticals sector. Its pages describe Finland acting as rapporteur in the EU centralised marketing authorisation procedure and as reference member state in the mutual recognition procedure. The European Medicines Agency states that the centralised procedure is compulsory for medicines with a new active substance to treat cancer. The coordinates are an approximate Helsinki city point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/